
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : IC 800
Therapeutic Area : Ophthalmology
Study Phase : IND Enabling
Sponsor : IACTA Pharmaceuticals
Deal Size : $100.0 million
Deal Type : Collaboration
IACTA Pharmaceuticals and Pharmaleads to Develop the World's First Epithelial Protective Drug
Details : Under the terms of these agreements, Pharmaleads and Pharmaleads Greater China have granted IACTA an exclusive, worldwide, royalty-bearing license to lead the clinical and commercial development of IC800 (acute) and IC805 and other DENKI drugs from Pharm...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
January 07, 2021
Lead Product(s) : IC 800
Therapeutic Area : Ophthalmology
Highest Development Status : IND Enabling
Sponsor : IACTA Pharmaceuticals
Deal Size : $100.0 million
Deal Type : Collaboration
